2,184
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Borneol and Α-asarone as adjuvant agents for improving blood–brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors

, ORCID Icon, , , , , , & show all
Pages 1858-1864 | Received 11 Jul 2018, Accepted 21 Aug 2018, Published online: 19 Oct 2018

References

  • Abbott NJ, Patabendige AaK, Dolman DEM, et al. (2010). Structure and function of the blood–brain barrier. Neurobiol Dis 37:13–25.
  • Cai Z, Lei X, Lin Z, et al. (2014). Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer. Acta Pharm Sin B 4:86–93.
  • Carman AJ, Mills JH, Krenz A, et al. (2011). Adenosine Receptor Signaling Modulates Permeability of the Blood–brain Barrier. J Neurosci 31:13272–80.
  • Carman CV, Springer TA. (2008). Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol 20:533–40.
  • Fredholm BB, Ijzerman AP, Jacobson KA, et al. (2011). International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63:1–34.
  • Fu BM. (2012). Experimental methods and transport models for drug delivery across the blood–brain barrier. CPB 13:1346–59.
  • Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. (2005). Colloidal carriers and blood–brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm 298:274–92.
  • Haseloff RF, Dithmer S, Winkler L, et al. (2015). Transmembrane proteins of the tight junctions at the blood–brain barrier: structural and functional aspects. Semin Cell Dev Biol 38:16–25.
  • Huber JD, Egleton RD, Davis TP. (2001). Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier. Trends Neurosci 24:719–25.
  • Kim DG, Bynoe MS. (2015). A2A Adenosine receptor regulates the human blood–brain barrier permeability. Mol Neurobiol 52:664–78.
  • Li W, Wu J, Zhang J, et al. (2018). Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Drug Deliv 25:827–37.
  • Liu RN, Xing DM, Lu H, et al. (2006). Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats. Am J Chin Med 34:1037–45.
  • Sheu JR, Kan YC, Hung WC, et al. (2000). The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci 67:937–47.
  • Sun YW, Jiang J, Zhang ZJ, et al. (2008). Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke. Bioorg Med Chem 16:8868–74.
  • Tornavaca O, Chia M, Dufton N, et al. (2015). ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol 208:821–38.
  • Wang JW, Wang HD, Cong ZX, et al. (2014a). Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. J Surg Res 186:328–37.
  • Wang LP, Feng JF, Hu KL. (2014b). Progress in regulation effect of aromatic refreshing traditional Chinese medicine on BBB permeability and its mechanism. Zhongguo Zhong Yao Za Zhi 39:949–54.
  • Wang N, Zhang YM, Wu L, et al. (2014c). Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. Neuropharmacol 79:282–9.
  • Wei SY, Chen Y, Xu XY. (2014). Progress on the pharmacological research of puerarin: a review. Chin J Nat Med 12:407–14.
  • Wu XD, Wang C, Zhang ZY, et al. (2014). Puerarin attenuates cerebral damage by improving cerebral microcirculation in spontaneously hypertensive rats. Evid Based Complement Alternat Med 2014:1.
  • Yang S, Zhang X, Xiang D. (2016). Comparison of pharmacokinetics of NaoDeSheng oral microemulsion and tablets. Chin Hosp Pharm J 36:728–31.
  • Yi T, Tang DD, Wang F, et al. (2017). Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Deliv 24:422–9.
  • Yuan Y, Zong J, Zhou H, et al. (2014). Puerarin attenuates pressure overload-induced cardiac hypertrophy. J Cardiol 63:73–81.
  • Zhang QL, Fu BMM, Zhang ZJ. (2017). Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability. Drug Deliv 24:1037–44.
  • Zhang X, Xiong J, Liu S, et al. (2014). Puerarin protects dopaminergic neurons in Parkinson’s disease models. Neurosci 280:88–98.
  • Zhong YF, Zhang XW, Cai XF, et al. (2014). Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. Plos One 9:e85690.
  • Zhu YQ, Yu J, Meng FH, et al. (2018). Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides. J Controlled Release 278:1–8.